Impact of age, gender, ethnicity and prior disease status on immunogenicity following administration of a single dose of the BNT162b2 mRNA Covid-19 Vaccine: real-world evidence from Israeli healthcare workers, December-January 2020

Kamal Abu Jabal, Hila Ben-Amram, Karine Beiruti, Yunis Batheesh, Christian Sussan, Salman Zarka, Michael Edelstein
doi: https://doi.org/10.1101/2021.01.27.21250567

Article usage

Article usage: January 2021 to August 2025

AbstractFullPdf
Jan 202112690471
Feb 20212554161102
Mar 20212817227
Apr 20212466114
May 2021154697
Jun 20211751096
Jul 202196273
Aug 20211351659
Sep 20211291156
Oct 202170838
Nov 202189340
Dec 202170013
Jan 202257515
Feb 202234013
Mar 202232114
Apr 20222907
May 202249214
Jun 202228211
Jul 20222607
Aug 20221915
Sep 202239111
Oct 202213107
Nov 20221913
Dec 202226212
Jan 20232217
Feb 202325314
Mar 20231315
Apr 20232826
May 20231929
Jun 20231145
Jul 20231026
Aug 2023191010
Sep 20231556
Oct 202323210
Nov 20231546
Dec 20231505
Jan 20241001
Feb 202417212
Mar 20241156
Apr 20241746
May 20241936
Jun 20241713
Jul 20241417
Aug 202421111
Sep 20242537
Oct 20241734
Nov 202416612
Dec 2024712
Jan 20251138
Feb 2025776
Mar 2025321510
Apr 20251838
May 20251978
Jun 2025171510
Jul 2025191016
Aug 2025111
Back to top
Posted January 31, 2021.
Download PDF
Data/Code
Email
Impact of age, gender, ethnicity and prior disease status on immunogenicity following administration of a single dose of the BNT162b2 mRNA Covid-19 Vaccine: real-world evidence from Israeli healthcare workers, December-January 2020
Kamal Abu Jabal, Hila Ben-Amram, Karine Beiruti, Yunis Batheesh, Christian Sussan, Salman Zarka, Michael Edelstein
medRxiv 2021.01.27.21250567; doi: https://doi.org/10.1101/2021.01.27.21250567
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area